Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Biphasic insulin aspart
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
NovoMix 30 FlexPen 100units/ml inj 3ml pre-filled pens
0601012W0BBABAB
|
NovoMix | Biphasic insulin aspart | Endocrine System | 118,614 |
|
NovoMix 30 Penfill 100units/ml inj 3ml cartridges
0601012W0BBAAAA
|
NovoMix | Biphasic insulin aspart | Endocrine System | 23,330 |
|
Insulin aspart biphasic 30/70 100u/ml inj 3ml pf dispos dev
0601012W0AAABAB
|
Insulin aspart biphasic | Biphasic insulin aspart | Endocrine System | 16 |
|
Insulin aspart biphasic 30/70 100units/ml inj 3ml cartridges
0601012W0AAAAAA
|
Insulin aspart biphasic | Biphasic insulin aspart | Endocrine System | 1 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.